{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T20:22:49Z","timestamp":1778962969710,"version":"3.51.4"},"reference-count":57,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1016\/j.thromres.2005.08.007","type":"journal-article","created":{"date-parts":[[2005,9,30]],"date-time":"2005-09-30T11:17:14Z","timestamp":1128079034000},"page":"321-333","source":"Crossref","is-referenced-by-count":163,"title":["Stroke prevention with aspirin, warfarin and ximelagatran in patients with non-valvular atrial fibrillation: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"118","author":[{"given":"Gregory Y.H.","family":"Lip","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven J.","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2005.08.007_bib1","series-title":"Cardiac arrhythmias: a clinical approach","first-page":"3","article-title":"Epidemiology and costs of cardiac arrhythmias","author":"Freestone","year":"2003"},{"key":"10.1016\/j.thromres.2005.08.007_bib2","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1136\/bmj.325.7371.1022","article-title":"ABC of antithrombotic therapy: antithrombotic therapy for atrial fibrillation","volume":"325","author":"Lip","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.thromres.2005.08.007_bib3","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3810\/pgm.2000.08.1185","article-title":"Anticoagulant use in nonvalvular atrial fibrillation: determining risk and choosing the safest course","volume":"108","author":"Gornick","year":"2000","journal-title":"Postgrad Med"},{"key":"10.1016\/j.thromres.2005.08.007_bib4","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1001\/jama.281.19.1830","article-title":"Preventing stroke in patients with atrial fibrillation","volume":"281","author":"Ezekowitz","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.thromres.2005.08.007_bib5","doi-asserted-by":"crossref","first-page":"492","DOI":"10.7326\/0003-4819-131-7-199910050-00003","article-title":"Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis","volume":"131","author":"Hart","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.thromres.2005.08.007_bib6","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1136\/bmj.322.7282.321","article-title":"Systematic review of long term anticoagulation or antiplatelet treatment in patients with non-rheumatic atrial fibrillation","volume":"322","author":"Taylor","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.thromres.2005.08.007_bib7","series-title":"The Cochrane Library, Issue 1","article-title":"Anticoagulation or antiplatelet therapy for non-rheumatic atrial fibrillation and flutter","author":"Segal","year":"2004"},{"key":"10.1016\/j.thromres.2005.08.007_bib8","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1001\/jama.288.19.2441","article-title":"Oral anticoagulants vs aspirin in non-valvular atrial fibrillation: an individual patient meta-analysis","volume":"288","author":"van Walraven","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.thromres.2005.08.007_bib9","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1001\/archinte.161.11.1443","article-title":"Are the results of randomized controlled trials on anticoagulation in patients with atrial fibrillation generalizable to clinical practice?","volume":"161","author":"Evans","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.thromres.2005.08.007_bib10","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1056\/NEJMoa022913","article-title":"Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation","volume":"349","author":"Hylek","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.thromres.2005.08.007_bib11","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1001\/jama.290.20.2685","article-title":"Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice?","volume":"290","author":"Go","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.thromres.2005.08.007_bib12","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1136\/bmj.316.7130.509","article-title":"Guidelines on anticoagulant treatment for atrial fibrillation in Great Britain: variation in content and implications for treatment","volume":"316","author":"Thomson","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/j.thromres.2005.08.007_bib13","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1136\/hrt.75.2.200","article-title":"Physician variation in the management of patients with atrial fibrillation","volume":"75","author":"Lip","year":"1996","journal-title":"Heart"},{"key":"10.1016\/j.thromres.2005.08.007_bib14","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1093\/qjmed\/94.11.609","article-title":"Managing atrial fibrillation in the Accident and Emergency Department","volume":"94","author":"Williams","year":"2001","journal-title":"QJM"},{"key":"10.1016\/j.thromres.2005.08.007_bib15","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1161\/hs0102.101817","article-title":"Ethnic differences in patient perceptions of atrial fibrillation and anticoagulation therapy: the West Birmingham Atrial Fibrillation Project","volume":"33","author":"Lip","year":"2002","journal-title":"Stroke"},{"key":"10.1016\/j.thromres.2005.08.007_bib16","first-page":"229","article-title":"Ximelagatran: the future in anticoagulation practice?","volume":"11","author":"Hamaad","year":"2004","journal-title":"Br J Cardiol"},{"key":"10.1016\/j.thromres.2005.08.007_bib17","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1016\/S0140-6736(03)14841-6","article-title":"Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial","volume":"362","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.thromres.2005.08.007_bib18","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1001\/jama.293.6.690","article-title":"Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a randomized trial","volume":"293","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.thromres.2005.08.007_bib19","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0895-4356(97)00049-8","article-title":"The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials","volume":"50","author":"Bucher","year":"1997","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.thromres.2005.08.007_bib20","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/S0197-2456(00)00055-6","article-title":"Indirect comparison in evaluating relative efficacy illustrated by antimicrobial prophylaxis in colorectal surgery","volume":"21","author":"Song","year":"2000","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.thromres.2005.08.007_bib21","first-page":"306","article-title":"Treatment of acute migraine attacks: comparative head-to-head-trials versus meta-analysis versus patient preference","volume":"21","author":"Diener","year":"2002","journal-title":"Nervenheilkunde"},{"key":"10.1016\/j.thromres.2005.08.007_bib22","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1136\/bmj.326.7387.472","article-title":"Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses","volume":"326","author":"Song","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.thromres.2005.08.007_bib23","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1056\/NEJM198312013092204","article-title":"Bias in treatment assignment in controlled clinical trials","volume":"309","author":"Chalmers","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1016\/j.thromres.2005.08.007_bib24","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.273.5.408","article-title":"Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.thromres.2005.08.007_bib25","first-page":"719","article-title":"Statistical aspects of the analysis of data from retrospective studies of disease","volume":"22","author":"Mantel","year":"1959","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.thromres.2005.08.007_bib26","unstructured":"Review Manager (RevMan) [Computer program]. Version 4.2 for Windows. Oxford, England: The Cochrane Collaboration; 2003."},{"key":"10.1016\/j.thromres.2005.08.007_bib27","unstructured":"StatsDirect Ltd. StatsDirect statistical software. http:\/\/www.statsdirect.com. England: StatsDirect Ltd; 2002."},{"key":"10.1016\/j.thromres.2005.08.007_bib28","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/BF00558064","article-title":"Multiple publication of reports of drug trials","volume":"36","author":"G\u00f8tzsche","year":"1989","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.thromres.2005.08.007_bib29","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1136\/bmj.295.6599.654","article-title":"Reference bias in reports of drug trials","volume":"295","author":"G\u00f8tzsche","year":"1987","journal-title":"BMJ"},{"key":"10.1016\/j.thromres.2005.08.007_bib30","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/0140-6736(91)90201-Y","article-title":"Publication bias in clinical research","volume":"337","author":"Easterbrook","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.thromres.2005.08.007_bib31","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1001\/jama.267.3.374","article-title":"Factors influencing publication of research results: follow-up of applications submitted to two institutional review boards","volume":"263","author":"Dickersin","year":"1992","journal-title":"JAMA"},{"key":"10.1016\/j.thromres.2005.08.007_bib32","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1136\/bmj.315.7109.640","article-title":"Publication bias: evidence of delayed publication in a cohort study of clinical research projects","volume":"315","author":"Stern","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.thromres.2005.08.007_bib33","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.thromres.2005.08.007_bib34","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.thromres.2005.08.007_bib35","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1136\/bmj.318.7197.1548","article-title":"Numbers needed to treat derived from meta-analyses \u2014 sometimes informative, usually misleading","volume":"318","author":"Smeeth","year":"1999","journal-title":"BMJ"},{"key":"10.1016\/j.thromres.2005.08.007_bib36","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1001\/jama.285.22.2864","article-title":"Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation","volume":"285","author":"Gage","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.thromres.2005.08.007_bib37","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0140-6736(89)91200-2","article-title":"Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation","volume":"1","author":"Petersen","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.thromres.2005.08.007_bib38","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1056\/NEJM199011293232201","article-title":"The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation","volume":"323","year":"1990","journal-title":"New Engl J Med"},{"key":"10.1016\/j.thromres.2005.08.007_bib39","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0735-1097(91)90585-W","article-title":"Canadian atrial fibrillation (CAFA) study","volume":"18","author":"Connolly","year":"1991","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.thromres.2005.08.007_bib40","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1161\/01.CIR.84.2.527","article-title":"Stroke prevention in atrial fibrillation study: final results","volume":"84","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2005.08.007_bib41","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1056\/NEJM199211123272002","article-title":"Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation","volume":"327","author":"Ezekowitz","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.thromres.2005.08.007_bib42","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/0140-6736(93)92358-Z","article-title":"Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke","volume":"342","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.thromres.2005.08.007_bib43","first-page":"687","article-title":"Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: stroke prevention in atrial fibrillation II study","volume":"343","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.thromres.2005.08.007_bib44","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1001\/archinte.156.4.409","article-title":"Bleeding during antithrombotic therapy in patients with atrial fibrillation","volume":"156","year":"1996","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.thromres.2005.08.007_bib45","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0140-6736(96)03487-3","article-title":"Adjusted-dose warfarin versus low-intensity, fixed dose warfarin plus aspirin for high-risk patients with atrial fibrillation: stroke prevention in atrial fibrillation III randomised controlled trial","volume":"348","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.thromres.2005.08.007_bib46","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1001\/archinte.158.14.1513","article-title":"Fixed minidose warfarin and aspirin alone and in combination vs adjusted-dose warfarin for stroke prevention in atrial fibrillation","volume":"158","author":"Gull\u00f8v","year":"1998","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.thromres.2005.08.007_bib47","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0002-9149(98)00357-9","article-title":"Effectiveness of fixed minidose warfarin in the prevention of thromboembolism and vascular death in nonrheumatic atrial fibrillation","volume":"82","author":"Pengo","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.thromres.2005.08.007_bib48","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1136\/bmj.319.7215.958","article-title":"Primary prevention of atrial thromboembolism in non-rheumatic atrial fibrillation in primary care: randomised controlled trial comparing two intensities of coumarin with aspirin","volume":"319","author":"Hellemons","year":"1999","journal-title":"BMJ"},{"key":"10.1016\/j.thromres.2005.08.007_bib49","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1161\/hs1201.099520","article-title":"Should stroke subtype influence anticoagulation decisions to prevent recurrence in stroke patients with atrial fibrillation?","volume":"32","author":"Evans","year":"2001","journal-title":"Stroke"},{"issue":"10","key":"10.1016\/j.thromres.2005.08.007_bib50","doi-asserted-by":"crossref","first-page":"745","DOI":"10.7326\/0003-4819-141-10-200411160-00005","article-title":"Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation","volume":"141","author":"Fang","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.thromres.2005.08.007_bib51","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1136\/jnnp.54.12.1044","article-title":"The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results","volume":"54","author":"Farrell","year":"1991","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.thromres.2005.08.007_bib52","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0002-8703(99)70259-0","article-title":"Alternate-day dosing of aspirin in atrial fibrillation","volume":"138","author":"Posada","year":"1999","journal-title":"Am Heart J"},{"key":"10.1016\/j.thromres.2005.08.007_bib53","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1600-0404.1999.tb00658.x","article-title":"Second European Stroke Prevention Study: antiplatelet therapy is effective regardless of age","volume":"99","author":"Sivenius","year":"1999","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.thromres.2005.08.007_bib54","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S0002-9149(02)02606-1","article-title":"Effectiveness of clopidogrel versus aspirin in preventing acute myocardial infarction in patients with symptomatic atherothrombosis (CAPRIE trial)","volume":"90","author":"Cannon","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.thromres.2005.08.007_bib55","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1161\/01.STR.31.4.817","volume":"31","author":"Yamaguchi","year":"2000","journal-title":"Stroke"},{"issue":"9","key":"10.1016\/j.thromres.2005.08.007_bib56","article-title":"Protocol for Birmingham Atrial Fibrillation Treatment of the Aged study (BAFTA): a randomised controlled trial of warfarin versus aspirin for stroke prevention in the management of atrial fibrillation in an elderly primary care population [ISRCTN89345269]","volume":"3","author":"Mant","year":"2003","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.thromres.2005.08.007_bib57","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S1474-4422(04)00738-0","article-title":"Warfarin for atrial fibrillation: the end of an era?","volume":"3","author":"Donnan","year":"2004","journal-title":"Lancet Neurol"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384805003543?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384805003543?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T14:36:37Z","timestamp":1553610997000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384805003543"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":57,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["S0049384805003543"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2005.08.007","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2006,1]]}}}